ERBB2 and breast carcinoma: However, previous studies have largely focused on general breast cancer imaging, often neglecting the specific characteristics of HER2 overexpressing breast cancer, a highly heterogeneous subtype with distinct treatment responses and imaging manifestations after NAT.